FISHER PHARMACEUTICALS
ActiveSummary
The computed 12-month bankruptcy probability of FISHER PHARMACEUTICALS is 1.9% (moderate). The 2025 annual accounts show equity of €3,617 and a net result of €1,617. Its solvency ranks better than 83% of 13,716 sector peers (NACE 46, financial year 2025). The company has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals.
Overview
Official details
Source: KBO- Status
- Active since 12-11-2024 Normal situation
- Activity
- Non-specialised wholesale trade NACE 46900and 2 others
- Establishment unit
- 2.370.538.359 1150 Sint-Pieters-Woluwe, since 08-12-2024
- Financial year end
- 30 June
- Peppol
- Reachable since 18-12-2025
Financial position
- Bankruptcy probabilitywithin 12 months
- 1.9%
- Gross margin
- €3,481
- Turnover
- ≈ €44,000
- estimated
- Profit
- €1,617
- Equity
- €3,617
- Total assets
- €4,503
Score breakdownraises riskFounded in 2024Size: total assets €4,503Liquidity: current ratio 0.06, cash €26lowers riskEquity €3,617 (80.3% of total assets)Show the evidence
Checked score
About 2 in 100 comparable companies go bankrupt within 12 months (an estimate).
Calculation
The band follows from the bankruptcy probability. 10 more points roughly halve it.
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 46, micro). It does better than 90% of them on solvency, 43% on liquidity and 95% on profitability.
The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Searched, nothing found (1)
Key points
- Positive: Higher solvency than 82% of companies in wholesale tradesector median 40.6% · 13,716 companies 80.3% View
Recent changes
- · Gazette deed IncorporationStarting capital €2,000 · Appointment: GHADIRI Azam (director)
Comparable companies
These companies have the same main activity as FISHER PHARMACEUTICALS: non-specialised wholesale trade (NACE 46900). They are comparable in size and age: total assets between €1,710 and €19,800, founded between 2023 and 2025.
| Company | Total assets | Gross margin |
|---|---|---|
| FISHER PHARMACEUTICALS Sint-Pieters-Woluwe | €4,503 | €3,481 |
| Prajna Essen | €4,095 | €3,978 |
| Brussels Beauty Exchange Ukkel | €9,563 | -€5,184 |
| BELHOME Kortenberg | €1,706 | -€6,532 |
| Worldproductscompany Turnhout | €8,355 | -€3,523 |
| Elevanty Brussel | €19,167 | -€1,649 |
| LABOUL Ukkel | €19,775 | €19,621 |
Key facts about FISHER PHARMACEUTICALS
- What is the company number of FISHER PHARMACEUTICALS?
- The company number of FISHER PHARMACEUTICALS is 1016.131.517. The VAT number is the same number with BE in front: BE 1016.131.517.
- Where is FISHER PHARMACEUTICALS based?
- The registered office is at Gebroeders Legrainlaan 76, 1150 Sint-Pieters-Woluwe.Company details
- What does FISHER PHARMACEUTICALS do?
- According to the KBO register, the main activity is non-specialised wholesale trade (NACE 46900).
- What is the legal form of FISHER PHARMACEUTICALS?
- The legal form of FISHER PHARMACEUTICALS is Private limited company (BV).
- When was FISHER PHARMACEUTICALS founded?
- FISHER PHARMACEUTICALS was founded on 12-11-2024.
- Is FISHER PHARMACEUTICALS still active?
- Yes, FISHER PHARMACEUTICALS is an active enterprise in the KBO register.
- What is the turnover of FISHER PHARMACEUTICALS?
- The turnover in financial year 2025 is ≈ €44,000. This figure is estimated from the gross margin of €3,481 and 216 comparable companies (NACE 46). It probably lies between €21,000 and €110,000. It is a rough estimate.Financials
- Is FISHER PHARMACEUTICALS profitable?
- In financial year 2025, FISHER PHARMACEUTICALS made a profit of €1,617.
- Where can I find the annual accounts of FISHER PHARMACEUTICALS?
- FISHER PHARMACEUTICALS filed 1 annual account with the National Bank of Belgium, for financial year 2025.
Next steps
See how customers, suppliers and banks see your own company and what to improve first.